Found: 148
Select item for more details and to access through your institution.
Additional hepatic <sup>166</sup>Ho-radioembolization in patients with neuroendocrine tumours treated with <sup>177</sup>Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Frequent Genetic Changes in Childhood Pheochromocytomas.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1073, n. 1, p. 166, doi. 10.1196/annals.1353.017
- By:
- Publication type:
- Article
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview.
- Published in:
- Pituitary, 2023, v. 26, n. 4, p. 333, doi. 10.1007/s11102-023-01325-4
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
Salvage Therapy with <sup>177</sup>Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 383, doi. 10.2967/jnumed.109.068957
- By:
- Publication type:
- Article
Effects of Therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³]Octreotate in Patients with Paraganglioma, Meningioma, Small Cell Lung Carcinoma, and Melanoma.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1599
- By:
- Publication type:
- Article
Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 76S
- By:
- Publication type:
- Article
The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.
- Published in:
- Endocrine Pathology, 2023, v. 34, n. 4, p. 437, doi. 10.1007/s12022-023-09768-y
- By:
- Publication type:
- Article
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
- Published in:
- Endocrine Pathology, 2022, v. 33, n. 1, p. 115, doi. 10.1007/s12022-022-09708-2
- By:
- Publication type:
- Article
Medical Therapy of Acromegaly: Efficacy and Safety of Somatostatin Analogues.
- Published in:
- Drugs, 2009, v. 69, n. 16, p. 2207, doi. 10.2165/11318510-000000000-00000
- By:
- Publication type:
- Article
Editorial: Early Genetic and Clinical Diagnosis in MEN1.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13639
- By:
- Publication type:
- Article
Risk Factors for Meningitis After Transsphenoidal Surgery.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. 4, p. 852
- By:
- Publication type:
- Article
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4675, doi. 10.1007/s12325-023-02627-6
- By:
- Publication type:
- Article
Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 1, p. K1, doi. 10.1093/ejendo/lvae075
- By:
- Publication type:
- Article
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 3, p. 399, doi. 10.1530/EJE-22-0339
- By:
- Publication type:
- Article
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using <sup>177</sup>Lu-DOTATATE.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 1, p. 45, doi. 10.1530/EJE-18-0901
- By:
- Publication type:
- Article
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
- Published in:
- European Journal of Endocrinology, 2016, v. 175, n. 5, p. 361, doi. 10.1530/EJE-16-0392
- By:
- Publication type:
- Article
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 4, p. 337, doi. 10.1530/EJE-14-0897
- By:
- Publication type:
- Article
Radionuclide therapy in neuroendocrine tumors.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 1, p. R1, doi. 10.1530/EJE-14-0488
- By:
- Publication type:
- Article
Functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs).
- Published in:
- European Journal of Endocrinology, 2014, v. 170, n. 5, p. R173, doi. 10.1530/EJE-14-0077
- By:
- Publication type:
- Article
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 1, p. 51, doi. 10.1530/EJE-13-0093
- By:
- Publication type:
- Article
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2013, v. 167, n. 1, p. 67, doi. 10.1530/EJE-12-0594
- By:
- Publication type:
- Article
Serum inhibin pro-&agr;C is a tumor marker for adrenocortical carcinomas.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 2, p. 281, doi. 10.1530/EJE-11-0693
- By:
- Publication type:
- Article
Diagnostic imaging of dopamine receptors in pituitary adenomas.
- Published in:
- European Journal of Endocrinology, 2007, v. 156, n. S1, p. S53, doi. 10.1530/eje.1.02349
- By:
- Publication type:
- Article
Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?
- Published in:
- European Journal of Endocrinology, 2006, v. 155, n. 5, p. 717, doi. 10.1530/eje.1.02281
- By:
- Publication type:
- Article
Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly.
- Published in:
- European Journal of Endocrinology, 2005, v. 153, n. 1, p. 67, doi. 10.1530/eje.1.01935
- By:
- Publication type:
- Article
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 4, p. 645, doi. 10.1530/eje.1.01876
- By:
- Publication type:
- Article
The bio-assay quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 2, p. 217, doi. 10.1530/eje.1.01838
- By:
- Publication type:
- Article
Effect of epigenetic treatment on SST<sub>2</sub> expression in neuroendocrine tumour patients.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.957
- By:
- Publication type:
- Article
Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 40, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with <sup>177</sup>LuDOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 452, doi. 10.2967/jnumed.117.189712
- By:
- Publication type:
- Article
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1647, doi. 10.2967/jnumed.115.158899
- By:
- Publication type:
- Article
Sequential ACTH and catecholamine secretion in a phaeochromocytoma.
- Published in:
- European Journal of Endocrinology, 2002, v. 147, n. 2, p. 201, doi. 10.1530/eje.0.1470201
- By:
- Publication type:
- Article
Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly.
- Published in:
- European Journal of Endocrinology, 2002, v. 147, n. 2, p. 195, doi. 10.1530/eje.0.1470195
- By:
- Publication type:
- Article
Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2000, v. 142, n. 5, p. 472
- By:
- Publication type:
- Article
Approach to the Patient: Insulinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 4, p. 1109, doi. 10.1210/clinem/dgad641
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3199, doi. 10.1210/clinem/dgac574
- By:
- Publication type:
- Article
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e1969, doi. 10.1210/clinem/dgac001
- By:
- Publication type:
- Article
Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article